Stockreport

BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family

BioCardia, Inc.  (BCDA) 
PDF SUNNYVALE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of car [Read more]